CREDIT SUISSE AG/ - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 62 filers reported holding SURFACE ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q1 2023$27,952
-14.8%
40,0000.0%0.00%
Q4 2022$32,800
-21.9%
40,0000.0%0.00%
Q3 2022$42,000
-36.4%
40,000
-0.0%
0.00%
Q2 2022$66,000
-47.6%
40,019
-6.3%
0.00%
Q1 2022$126,000
-41.1%
42,718
-4.9%
0.00%
Q4 2021$214,000
+23.7%
44,914
+79.5%
0.00%
Q3 2020$173,00025,0150.00%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
Atlas Venture Associates XI, LLC 2,945,453$27,216,0004.31%
Atlas Venture Associates IX, LLC 2,945,453$27,216,0004.31%
ACUTA CAPITAL PARTNERS, LLC 999,500$9,235,0002.51%
COMMODORE CAPITAL LP 467,796$4,322,0002.35%
Ghost Tree Capital, LLC 1,000,000$9,240,0002.06%
VR Adviser, LLC 1,442,895$13,332,0001.96%
SILVERARC CAPITAL MANAGEMENT, LLC 130,000$1,201,0000.70%
Parkman Healthcare Partners LLC 175,792$1,624,0000.42%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 26,732$247,0000.39%
One68 Global Capital, LLC 15,071$139,0000.28%
View complete list of SURFACE ONCOLOGY INC shareholders